176
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Individual characterization of stably expanded T cell clones in ankylosing spondylitis patients

, , , , , , , , , , , , , & show all
Pages 525-536 | Received 10 Feb 2009, Accepted 08 Apr 2009, Published online: 09 Sep 2009
 

Abstract

Ankylosing spondylitis (AS) is commonly characterized by clonal expansions of T cells. However, these clonal populations are poorly studied and their role in disease initiation and progression remains unclear. Here, we performed mass sequencing of TCR V beta libraries to search for the expanded T cell clones for two AS patients. A number of clones comprising more than 5% of the corresponding TCR V beta family were identified in both patients. For the first time, expanded clones were shown to be stably abundant in blood samples of AS patients for the prolonged period (1.5 and 2.5 years for two patients, correspondingly). These clones were individually characterized in respect to their differentiation status using fluorescent cell sorting with CD27, CD28, and CD45RA markers followed by quantitative identification of each clone within corresponding fraction using real time PCR analysis. Stable clones differed in phenotype and several were shown to belong to the proinflammatory CD27 − /CD28 − population. Their potentially cytotoxic status was confirmed by staining with perforin-specific antibodies. Search for the TCR V beta CRD3 sequences homologous to the identified clones revealed close matches with the previously reported T cell clones from AS and reactive arthritis patients, thus supporting their role in the disease and proposing consensus TCR V beta CDR3 motifs for AS. Interestingly, these motifs were also found to have homology with earlier reported virus-specific CDR3 variants, indicating that viral infections could play role in development of AS.

Acknowledgements

We thank Ilya Yampolsky and Ekaterina Zvezdova for the help in manuscript preparation. This work was supported by two grants from Molecular and Cell Biology Program RAS for D.M.C. and Y.B.L., by grants from the Howard Hughes Medical Institute (55005618), Rosnauka (02.512.12.2053), “State Support of the Leading Scientific Schools” (NS-2395.2008.4), and Basic Research for Medicine RAS. D.M.C. and I.Z.M. are supported by Grants of the President of Russian Federation (MK-6119.2008.4). Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.